Market revenue in 2023 | USD 1,721.4 million |
Market revenue in 2030 | USD 2,872.0 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Insulin delivery devices |
Fastest growing segment | Insulin Delivery Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices |
Key market players worldwide | Medtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.
Insulin delivery devices was the largest segment with a revenue share of 54.19% in 2023. Horizon Databook has segmented the Latin America diabetes devices market based on blood glucose monitoring (bgm) devices, insulin delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America diabetes devices market is primarily driven by Brazil, Mexico, Argentina, and Colombia. Growing investments by market players in the region, proximity to North America, and free-trade agreements with major countries such as the U.S., Canada, Japan, & several European countries are among the factors anticipated to boost the Latin America market during the forecast period.
Latin America consists of countries that have large populations, and the majority of these countries are in economic transition. This region has a younger age distribution in comparison to North America and a growing population has been diagnosed with type I and type II diabetes.
In 2021, mortality rates due to diabetes in the region were 410,000 in the region. Increasing awareness in the region about the disease has led to a substantial number of diagnosed numbers escalating the demand for glucose monitoring devices. Major investments by key market players in the emerging economy and presence of a large target population are factors expected to drive market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America diabetes devices market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America diabetes devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account